Beneficial effects of 5-fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer (vol 10, pg 250, 2010)

Aiura Koichi; Takahashi Shin; Matsui Junichi; Ueda Masakazu; Kitagawa Yuko

首页> 外文期刊>Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] >Beneficial effects of 5-fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer (vol 10, pg 250, 2010)

【24h】

Beneficial effects of 5-fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer (vol 10, pg 250, 2010)

机译：5-氟尿嘧啶和肝素的门式输注化疗的有益效果联合粉刺切除术后丝霉素C和顺铂（Vol 10，PG 250,10010）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] 》 |2017年第2期| 共2页
作者
Aiura Koichi; Takahashi Shin; Matsui Junichi; Ueda Masakazu; Kitagawa Yuko;
展开▼
作者单位

Keio Univ Sch Med Dept Surg Tokyo Japan;

Nippon Kohkan Hosp Dept Surg Kawasaki Kanagawa Japan;

Ichikawa Gen Hosp Tokyo Dent Coll Dept Surg Chiba Japan;

Keio Univ Sch Med Dept Surg Tokyo Japan;

Keio Univ Sch Med Dept Surg Tokyo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病 ;
关键词

相似文献

外文文献
中文文献

1. Beneficial effects of 5-fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer (vol 10, pg 250, 2010) [J] . Aiura Koichi, Takahashi Shin, Matsui Junichi, Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] . 2017 ,第2期

机译：5-氟尿嘧啶和肝素的门式输注化疗的有益效果联合粉刺切除术后丝霉素C和顺铂（Vol 10，PG 250,10010）
2. Post-operative adjuvant chemotherapy for colorectal cancer with 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration after curative resection. [J] . Iwagaki H, Tanaka N, Esato K, Anticancer Research: International Journal of Cancer Research and Treatment . 2001 ,第6Appa期

机译：大肠癌术后根治性切除后联合5-氟尿嘧啶（5-FU）输注联合1-己基氨基甲酰基-5-氟尿嘧啶（HCFU）的大肠癌术后辅助化疗。
3. Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma. [J] . Kim do Y, Ahn SH, Kim SU, Oncology: International Journal of Cancer Research and Treatment . 2011 ,第3a4期

机译：根治性切除肝细胞癌后，使用5-氟尿嘧啶和顺铂进行辅助性肝动脉灌注化疗。
4. Phase I trial of split-dose induction docetaxel cisplatin and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1) [O] . Katrin Oertel, Karin Spiegel, Harald Schmalenberg, 2012

机译：局部晚期口腔和口咽鳞状细胞癌（TISOC-1）患者的分剂量诱导多西他赛顺铂和5-氟尿嘧啶（TPF）化疗+根治性手术联合术后放疗的I期试验
5. Table 5.5.a.1 Tumor size and treatment (rate of resectability) Figure 5.5.a.2 Cumulative survival of the patients after pancreatectomy for TS1 cancer according to residual tumors Figure 5.5.a.3 Cumulative survival of the patients with TS1 cancer according to extent of lymph node dissection Figure 5.5.a.4 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.5 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.6 Combined resection of peripancreatic plexus when there is no plexus infiltration and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.7 Combined resection of artery and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.8 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.9 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head [O] . 2007

机译：表5.5.a.1肿瘤大小和治疗（重新切性率）图5.5.a.2根据残留肿瘤对TS1癌胰腺切除后患者的累积存活图5.5.A.3累积存活根据淋巴结解剖的程度，TS1癌症的患者图5.5.A.4在胰头胰腺IIA或IIB癌症术后胰岛切除术后的门静脉和累积患者的累积存活图5.5。 A.5在胰头术后IIA或IIB胰腺切除术后，患者胰腺癌丛和患者累积存活的组合图5.5.A.6当没有丛浸润时，围裙丛生的围嘴巴丛的切除胰腺切除术后胰腺切除术后胰腺炎癌症的累积存活图5.5.A.7在TS1癌症胰腺切除后患者的动脉和累积存活的组合UICC阶段IIA或IIB在胰头图5.5.A.8在胰头胰腺阶段IIA或IIB癌症的胰腺切除后，患者的门静脉和累积患者的累积存活率图5.5.A.9在胰头胰腺阶段IIA或IIB的胰腺切除术后胰腺切除术后患者患者患者患者的累积生存的组合和胰腺头

Beneficial effects of 5-fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer (vol 10, pg 250, 2010)

著录项

相似文献

相关主题

期刊订阅